Viral modulation of the anti-glioblastoma immune response: rewiring host immunity to recognize & kill brain cancer
Glioblastoma (GBM) is a universally fatal solid malignancy of the central nervous system (CNS), hallmarked by a high mitotic index, intercellular heterogeneity, and low neo-antigen burden. Standard of care including surgery, radiation, and chemotherapy has failed to improve life expectancy beyond 15...
Päätekijä: | |
---|---|
Muut tekijät: | |
Aineistotyyppi: | Opinnäyte |
Kieli: | English |
Julkaistu: |
2022
|
Aiheet: |